5 Key Takeaways

• 1

  Myopia control treatments should not be stopped based solely on refractive stabilization, as axial length may continue to increase.

• 2

  Refractive error stability does not guarantee the absence of myopia-related complications, such as retinal detachment and glaucoma.

• 3

  Factors influencing myopia progression include age of onset, parental history, academic stress, and outdoor activity.

• 4

  Cessation of treatment can lead to rebound phenomena, particularly with pharmacologic treatments like atropine.

• 5

  Clinicians should monitor axial length trends and consider tapering treatment rather than abrupt cessation for myopia management.